Sun Pharmaceutical Industries today said it has received approval from the US health regulator to launch the generic version of Eli Lilly's schizophrenia treatment drug, Zyprexa in the American market.
The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of olanzapine tablets in multiple dosages of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg, the company said in a statement.
Sun Pharma said olanzapine tablets have annual sale of about $3.3 billion in the US.
These tablets are indicated for treatment of schizophrenia, bipolar I disorder which are associated with manic or mixed episodes.
Sun Pharma scrip was trading at Rs 597.10 in the afternoon on the BSE, up 0.33% from the previous close.
